주문제작 서비스 문의
찾으시는 제품이 저희 사이트에 없으신가요? 단백질 주문 제작 서비스를 이용해보세요!
주문제작 서비스 문의 >>
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Fill out organ-on-a-chip questionnaire to win a FREE gift! Fill out organ-on-a-chip questionnaire to win a FREE gift!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
>
전시회 >
Webinar: Using E. coli To Identify Stability Liabilities in Therapeutic and Disease-Causing ProteinsACROBiosystems is proud to sponsor the webinar “Using E. coli To Identify Stability Liabilities in Therapeutic and Disease-Causing Proteins”!
This webinar will be hosted live and available on-demand
Thursday, December 8, 2022 | 8am PST | 11am EST
Many years have passed since recombinant human insulin, the first medicine made via recombinant DNA technology, was approved by the FDA. The continuous rise in the approval of protein therapeutics demonstrates the potential that biopharmaceuticals have to become the medicines of the future.
This exclusive Technology Networks webinar focuses on the most recent and innovative strategies for therapeutic antibody development and production. Your speaker, Professor Brockwell, will describe the development and use of a new assay to investigate important proteins in disease screening and the biopharmaceutical industry.
Attend this webinar to:
· Hear more about monoclonal antibodies and their impact
· Discover incredible studies and recent developments in this field
· Follow the development of a new assay used to investigate important proteins in biopharma
Speaker Information:
This web search service is supported by Google Inc.